{"transactions":[{"id":4623278,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-21T20:24:49.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2775,"price":3.39,"value":9407.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":382323,"source":{"system":"sec-edgar","filing":"0001470831-26-000895","document":"wk-form4_1790022287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000895/wk-form4_1790022287.xml","form_type":"4"}},{"id":4623277,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-21T20:24:49.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023."}],"balance_after":385098,"source":{"system":"sec-edgar","filing":"0001470831-26-000895","document":"wk-form4_1790022287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000895/wk-form4_1790022287.xml","form_type":"4"}},{"id":897363,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":15381,"price":1.89,"value":29070.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":385098,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897362,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":30950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":400479,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897361,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1863,"price":1.89,"value":3521.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":400479,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897360,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025."}],"balance_after":402342,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":897359,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:04:45.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":402342,"source":{"system":"sec-edgar","filing":"0001470831-26-000175","document":"wk-form4_1771452283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083126000175/wk-form4_1771452283.xml","form_type":"4"}},{"id":1035714,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-19T16:13:49.000Z","date":"2025-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2775,"price":3.32,"value":9213.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":162342,"source":{"system":"sec-edgar","filing":"0001470831-25-000223","document":"wk-form4_1758312827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083125000223/wk-form4_1758312827.xml","form_type":"4"}},{"id":1035713,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-19T16:13:49.000Z","date":"2025-09-18","kind":"exercise","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023."}],"balance_after":165117,"source":{"system":"sec-edgar","filing":"0001470831-25-000223","document":"wk-form4_1758312827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000147083125000223/wk-form4_1758312827.xml","form_type":"4"}},{"id":1264269,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":130600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":130600,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":130600},"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1264268,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4559,"price":3.18,"value":14497.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":165117,"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1264267,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":87100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":169676,"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1264266,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:54:48.000Z","date":"2025-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1863,"price":3.2,"value":5961.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":82576,"source":{"system":"sec-edgar","filing":"0001662579-25-000016","document":"wk-form4_1739915682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257925000016/wk-form4_1739915682.xml","form_type":"4"}},{"id":1369274,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2024-11-12T16:17:32.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":10500,"derivative":{"expiration_date":"2025-02-28","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001662579-24-000103","document":"wk-form4_1731446246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000103/wk-form4_1731446246.xml","form_type":"4"}},{"id":1369273,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-12T16:17:32.000Z","date":"2024-11-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1102,"price":6.04,"value":6656.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person."}],"balance_after":84439,"source":{"system":"sec-edgar","filing":"0001662579-24-000103","document":"wk-form4_1731446246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000103/wk-form4_1731446246.xml","form_type":"4"}},{"id":1369272,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-12T16:17:32.000Z","date":"2024-11-07","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":85541,"source":{"system":"sec-edgar","filing":"0001662579-24-000103","document":"wk-form4_1731446246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000103/wk-form4_1731446246.xml","form_type":"4"}},{"id":1401743,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-20T16:13:50.000Z","date":"2024-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1837,"price":6.38,"value":11720.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units and does not represent a sale by the Reporting Person."}],"balance_after":81791,"source":{"system":"sec-edgar","filing":"0001662579-24-000086","document":"wk-form4_1726863223.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000086/wk-form4_1726863223.xml","form_type":"4"}},{"id":1405460,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2024-09-17T17:12:26.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":14250,"derivative":{"expiration_date":"2025-02-28","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001662579-24-000082","document":"wk-form4_1726607540.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000082/wk-form4_1726607540.xml","form_type":"4"}},{"id":1405459,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-17T17:12:26.000Z","date":"2024-09-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":661,"price":6.36,"value":4203.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person."}],"balance_after":83628,"source":{"system":"sec-edgar","filing":"0001662579-24-000082","document":"wk-form4_1726607540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000082/wk-form4_1726607540.xml","form_type":"4"}},{"id":1405458,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-09-17T17:12:26.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":2250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit (\"PRSU\") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones."}],"balance_after":84289,"source":{"system":"sec-edgar","filing":"0001662579-24-000082","document":"wk-form4_1726607540.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000082/wk-form4_1726607540.xml","form_type":"4"}},{"id":1587220,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T19:21:58.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in sixteen equal quarterly installments, with the first installment vested on May 14, 2022, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":45000,"derivative":{"exercise_price":19,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001662579-24-000026","document":"wk-form4_1709943708.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000026/wk-form4_1709943708.xml","form_type":"4"}},{"id":1587219,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-08T19:21:58.000Z","date":"2024-03-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 7, 2024, the Compensation Committee of the Issuer's Board of Directors approved an option repricing. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable in sixteen equal quarterly installments, with the first installment vested on May 14, 2022, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":22.71,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001662579-24-000026","document":"wk-form4_1709943708.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000026/wk-form4_1709943708.xml","form_type":"4"}},{"id":1641323,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T17:02:35.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":165300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024."}],"balance_after":165300,"derivative":{"exercise_price":7.31,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":165300},"source":{"system":"sec-edgar","filing":"0001662579-24-000014","document":"wk-form4_1708034519.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000014/wk-form4_1708034519.xml","form_type":"4"}},{"id":1641322,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-15T17:02:35.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":36700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025."}],"balance_after":82039,"source":{"system":"sec-edgar","filing":"0001662579-24-000014","document":"wk-form4_1708034519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000014/wk-form4_1708034519.xml","form_type":"4"}},{"id":1641321,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-15T17:02:35.000Z","date":"2024-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":1301,"price":6.53,"value":8495.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":45339,"source":{"system":"sec-edgar","filing":"0001662579-24-000014","document":"wk-form4_1708034519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257924000014/wk-form4_1708034519.xml","form_type":"4"}},{"id":1777761,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-19T19:21:19.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":111000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of this option shall vest and become exercisable on September 18, 2024, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":111000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-09-17","underlying":"Common Stock","underlying_shares":111000},"source":{"system":"sec-edgar","filing":"0001662579-23-000097","document":"wk-form4_1695165671.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257923000097/wk-form4_1695165671.xml","form_type":"4"}},{"id":1777760,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65930,"kind":"person","name":"Adams Kendra","position":1,"cik":"0001991929","reported_name":"Adams Kendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-19T19:21:19.000Z","date":"2023-09-18","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on September 18, 2024, subject to the Reporting Person's continued service on each vesting date."}],"balance_after":46640,"source":{"system":"sec-edgar","filing":"0001662579-23-000097","document":"wk-form4_1695165671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991929/000166257923000097/wk-form4_1695165671.xml","form_type":"4"}}]}